Bg pattern

XILONIBSA 10 mg/puff, cutaneous spray solution

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use XILONIBSA 10 mg/puff, cutaneous spray solution

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Leaflet: information for the user

Xilonibsa 10 mg/spray, solution for cutaneous spraying

Lidocaine

Read this leaflet carefully before starting to use this medicine, as it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor.
  • This medicine has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor, even if they are not listed in this leaflet. See section 4.

Contents of the leaflet

  1. What Xilonibsa 10 mg/spray is and what it is used for
  2. What you need to know before starting to use Xilonibsa 10 mg/spray
  3. How to use Xilonibsa 10 mg/spray
  4. Possible side effects
  5. Storage of Xilonibsa 10 mg/spray
  6. Package contents and additional information

1. What Xilonibsa 10 mg/spray is and what it is used for

Xilonibsa 10 mg/spray contains lidocaine and belongs to the group of local anesthetics of the amide type.

Xilonibsa 10 mg/spray is indicated for superficial anesthesia of the mucosa in surgery, obstetrics, dentistry, and otorhinolaryngology.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to use Xilonibsa 10 mg/spray

Do not use Xilonibsa 10 mg/spray:

  • if you are allergic to lidocaine or to anesthetics of the amide type or to any of the other components of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor before starting to take Xilonibsa 10 mg/spray:

  • if you are an elderly and debilitated person.
  • if you suffer from epilepsy, hypovolemia, atrioventricular block, or other conduction disorders.
  • if you have bradycardia or impaired respiratory function.
  • if you have impaired liver function.
  • if you suffer from heart and circulatory failure.
  • if you suffer from renal impairment.

Excessive doses should be avoided, as well as the application of the medicine to infected or inflamed tissues, as the absorption of lidocaine is very rapid in these cases, and systemic adverse reactions may occur.

Eye contact with lidocaine should be avoided. In case of eye contact, if necessary, remove the contact lenses from the person. Wash immediately and abundantly with water for 15 minutes, keeping the eyelids apart. Do not let the water flow towards the unaffected eye. Perform immediate complementary treatments with an ophthalmologist.

Patients being treated with antiarrhythmic drugs of class III (e.g., amiodarone) should be closely monitored and electrocardiogram (ECG) monitoring should be considered, as cardiac effects may be additive.

Children

Xilonibsa 10 mg/spray is not recommended for use in children under 6 years of age due to the risk of rapid absorption of the anesthetic and the risk of reflex laryngospasm in the newborn.

Lidocaine should be used with caution in children over 6 years of age, not exceeding the maximum recommended dose.

Taking Xilonibsa 10 mg/spray with other medicines

Tell your doctor if you are using, have recently used, or may need to use any other medicine.

In particular, inform your doctor if you have recently used or have received treatment with any of the following medicines:

  • Medicines used to treat epilepsy, such as phenytoin.
  • Medicines used to treat AIDS (atazanavir, darunavir).
  • Other local or general anesthetics (halothane).
  • Diuretic medicines (acetazolamide, loop diuretics, and thiazides).
  • Cimetidine or beta-blockers.

Using Xilonibsa 10 mg/spray with food and drinks

It is recommended not to ingest food or liquids until sensitivity is regained to prevent the risk of biting in the mouth.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine.

Pregnancy

Xilonibsa 10 mg/spray is not recommended during pregnancy, as it crosses the placental barrier. However, no evidence of congenital anomalies has been demonstrated.

The use of Xilonibsa 10 mg/spray during pregnancy will be reserved only for those cases where the potential benefit justifies the possible risks to the fetus.

Breastfeeding

Xilonibsa 10 mg/spray is excreted in breast milk, but at therapeutic doses used, no effects are expected in newborns/children during breastfeeding.

Fertility

No effects on fertility have been reported with Xilonibsa 10 mg/spray.

Driving and using machines

The influence of Xilonibsa 10 mg/spray on the ability to drive and use machines is small.

Depending on the dose and place of administration, local anesthetics may affect mental function and temporarily alter locomotion and coordination. When administering this medicine, the doctor should assess each particular case to determine if the reaction capacity is compromised and if the patient can drive or use machines.

Xilonibsa 10 mg/spray may cause dizziness, sedation, blurred vision, and dizziness. If any of these side effects occur after applying Xilonibsa 10 mg/spray, you should wait until they cease before driving or using machinery.

Xilonibsa 10 mg/spray contains ethanol

This medicine contains 241 mg of alcohol (ethanol) per ml. It may cause a burning sensation on damaged skin.

3. How to use Xilonibsa 10 mg/spray

Xilonibsa 10 mg/spray will be administered by your doctor.

The lowest dose that provides the required anesthetic effect should be administered, avoiding excessive doses.

No more than 20 sprays should be applied to produce the desired anesthesia in adults.

In dentistry

It is recommended to administer 1 to 5 applications to the mucosa.

In otorhinolaryngology

When used for maxillary sinus puncture, it is recommended to apply 3 sprays.

In gynecology-obstetrics

It is recommended to apply approximately 20 sprays (equivalent to 200 mg).

Keep in mind that the maximum dose in 24 hours for an adult weighing approximately 70 kg is 200 mg (corresponding to 20 applications with the dosing valve). No more than 20 applications should be administered per adult patient. If dosing is based on patient weight, the dose should not exceed 3 mg/kg body weight per day.

Use in children

The dose of lidocaine in children should be adjusted according to the nature of the procedure and the patient's characteristics. In children over 6 years of age, the maximum dose will be calculated based on body weight, taking the dose of 3 mg/kg body weight per day as the maximum recommended daily dose.

Xilonibsa 10 mg/spray is not recommended for use in children under 6 years of age.

If you use more Xilonibsa 10 mg/spray than you should

As with other local anesthetics, due to excessive dosing or rapid absorption, systemic reactions may occur that can affect the central nervous system and the cardiovascular system. In these cases, treatment will consist of maintaining vital signs, and if convulsions appear, administering short-acting barbiturates (such as thiopental) or benzodiazepines (diazepam) intravenously.

In case of overdose or accidental ingestion, consult the Toxicological Information Service. Telephone 91 562 04 20.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone gets them.

Xilonibsa 10 mg/spray may cause local irritation (coughing, sneezing) at the time of application or immediately after.

Other adverse reactions that may be observed with the use of this medicine are:

Rare side effects (may affect up to 1 in 1000 patients).

Cardiac disorders: Hypotension, arrhythmias, bradycardia, cardiovascular arrest.

Nervous system disorders: Metallic taste, tinnitus, dizziness, nausea, vomiting, anxiety, tremors, nystagmus, headache, increased respiratory rate, paresthesia (loss of sensitivity accompanied by burning) of the lip and/or tongue, unconsciousness, and convulsions, coma, and respiratory arrest (in case of overdose).

Respiratory disorders: Tachypnea followed by bradypnea, which may cause apnea.

Very rare side effects (may affect up to 1 in 10,000 patients).

General disorders and administration site conditions:Allergic reactions, skin rash, erythema, pruritus, edema of the tongue, mouth, lips, or throat, and, in severe cases, anaphylactic shock.

Reporting side effects

If you experience any side effects, consult your doctor, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Xilonibsa 10 mg/spray

Keep this medicine out of the sight and reach of children.

Do not store above 25°C.

Keep in the original packaging to protect from light.

Do not use this medicine after the expiration date stated on the packaging. The expiration date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.

6. Package contents and additional information

Composition of Xilonibsa 10 mg/spray

  • The active ingredient is lidocaine.
  • The other excipients are ethanol 96%, menthol, saccharin, macrogol 400, banana flavor, and purified water.

Appearance of the product and package contents

Xilonibsa 10 mg/spray is a clear or practically clear solution with a characteristic odor.

Xilonibsa 10 mg/spray is presented in a 50 ml bottle containing approximately 500 sprays. Each bottle contains a dosing valve that provides a dose of 10 mg of lidocaine per spray.

Marketing authorization holder and manufacturer

Laboratorios Inibsa, S.A.

Ctra. Sabadell a Granollers, km. 14,5

08185 Lliçà de Vall (Barcelona)

Spain

Telephone: +34 938 609 500

Fax: +34 938 439 695

e-mail: [email protected]

Local representative

LAPHYSAN S.A.U.

Anabel Segura, 11 Edificio A, Planta 4, Puerta D

28108 Alcobendas (Madrid)

Spain

Date of the last revision of this leaflet: May 2016

Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/

Online doctors for XILONIBSA 10 mg/puff, cutaneous spray solution

Discuss questions about XILONIBSA 10 mg/puff, cutaneous spray solution, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (29)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60
5.0 (2)
Doctor

Svetlana Kolomeeva

Cardiology 18 years exp.

Dr. Svetlana Kolomeeva is a general practitioner and internal medicine doctor providing online consultations for adults. She helps patients manage acute symptoms, chronic conditions, and preventive care. Her clinical focus includes cardiovascular health, hypertension control, and managing symptoms like fatigue, weakness, sleep issues, and overall low energy.

Patients commonly seek her help for:

  • High blood pressure, headaches, dizziness, swelling, palpitations.
  • Diagnosis and management of hypertension, arrhythmias, and tachycardia.
  • Metabolic syndrome, excess weight, high cholesterol.
  • Chronic fatigue, insomnia, poor concentration, anxiety.
  • Respiratory symptoms: colds, flu, sore throat, cough, fever.
  • Digestive issues: heartburn, bloating, constipation, IBS symptoms.
  • Chronic conditions: diabetes, thyroid disorders.
  • Interpretation of lab tests and medical reports, therapy adjustment.
  • Second opinion and decision-making support.
  • Cardiovascular disease prevention and metabolic risk reduction.
  • Long-term follow-up and dynamic health monitoring.

Dr Kolomeeva combines clinical expertise with personalised care. She clearly explains diagnoses, guides patients through symptoms and treatment options, and provides actionable plans. Her consultations are designed not only to address current complaints but also to stabilise chronic conditions and prevent future complications. She supports patients through every stage of care – from first symptoms to ongoing health management.

Camera Book a video appointment
€55
0.0 (0)
Doctor

Maria Martelli

Pain medicine 12 years exp.

Dr Maria Martelli is a medical doctor specialising in anaesthesiology and pain medicine. She provides online consultations for adults, focusing on the assessment and management of acute, chronic, and complex pain conditions, as well as supportive care in serious illness.

She graduated from the Medical University of Silesia in Katowice and completed her specialisation in Anaesthesiology and Intensive Care. Alongside hospital work, she has extensive experience in home and inpatient hospice care, supporting patients with severe pain and advanced disease. Since 2021, she has been a certified specialist and continues to work in anaesthesiology, intensive care, and pain treatment.

Patients consult her for:

  • Chronic pain lasting more than 3 months (musculoskeletal, neuropathic, mixed pain).
  • Acute pain requiring medical assessment and treatment planning.
  • Post-operative pain and recovery support.
  • Cancer-related pain and symptom relief.
  • Palliative care support and quality-of-life improvement.
  • Adjustment and optimisation of pain medication.
  • Second opinions for complex or treatment-resistant pain.
Dr Martelli takes a structured, evidence-based approach, carefully analysing symptoms, previous treatments, and overall health status. Her consultations focus on realistic pain control goals, safety of therapy, and improving daily functioning.

She is especially attentive to patients living with long-term pain or serious illness, providing clear explanations, compassionate guidance, and medically sound recommendations adapted to each individual situation.

Camera Book a video appointment
€99
0.0 (1)
Doctor

Daria Portnova

Psychiatry 31 years exp.

Dr Daria Portnova is a psychiatrist and psychotherapist with over 30 years of clinical experience. She works with adults and adolescents aged 14 and over, providing online psychiatric and psychotherapeutic consultations.

In her practice, Dr Portnova supports patients facing the onset of mental health conditions, chronic psychiatric disorders, psychotic symptoms, trauma-related states, and complex emotional crises. Her work is structured and safety-focused, with an emphasis on stabilisation, accurate diagnosis, and long-term improvement in quality of life.

Patients consult Dr Daria Portnova for the following concerns:

  • existential crises and complex life situations;
  • loss, grief, and emotional exhaustion;
  • relationship difficulties, separation, and divorce;
  • psychological and psychiatric trauma, including complex PTSD (cPTSD);
  • anxiety disorders: generalised anxiety disorder and panic disorder;
  • social anxiety and social phobia;
  • obsessive-compulsive disorder (OCD);
  • sleep disorders;
  • depressive disorders;
  • bipolar affective disorder;
  • schizoaffective disorder;
  • schizophrenia;
  • personality disorders.
Dr Portnova combines psychiatric assessment with a psychotherapeutic approach. She works with evidence-based methods, including cognitive behavioural therapy (CBT) and third-wave approaches such as ACT, FACT, and CFT. Consultations are focused on clear clinical understanding, practical recommendations, and ongoing support over time.
Camera Book a video appointment
€110
5.0 (77)
Doctor

Sergey Ilyasov

Psychiatry 7 years exp.

Dr Sergey Ilyasov is an experienced neurologist and qualified psychiatrist who provides online consultations for adults and adolescents. Combining deep neurological expertise with a modern psychiatric approach, he ensures comprehensive diagnostics and effective treatment for a wide range of conditions affecting both physical and mental health.

Dr. Ilyasov helps patients in the following cases:

  • Chronic headaches (migraine, tension-type headache), back pain, neuropathic pain, dizziness, numbness in limbs, coordination disorders.
  • Anxiety disorders (panic attacks, generalized anxiety disorder), depression (including atypical and treatment-resistant forms), sleep disturbances (insomnia, hypersomnia, nightmares), stress, burnout.
  • Chronic pain syndromes and psychosomatic symptoms (e.g., irritable bowel syndrome related to stress, vegetative-vascular dystonia).
  • Behavioral disorders and concentration difficulties in adolescents (including ADHD, autism spectrum disorders), nervous tics.
  • Memory impairments, phobias, obsessive-compulsive disorder (OCD), emotional swings, and support for post-traumatic stress disorder (PTSD).

Thanks to his dual specialization in neurology and psychiatry, Dr Sergey Ilyasov offers integrated and evidence-based care for complex conditions requiring a multidisciplinary approach. His consultations focus on accurate diagnosis, development of an individualized treatment plan (including pharmacotherapy and psychotherapeutic methods), and long-term support adapted to each patient's unique needs.

Book an online consultation with Dr. Sergey Ilyasov to receive qualified assistance and improve your well-being today.

Camera Book a video appointment
€89

Frequently Asked Questions

Is a prescription required for XILONIBSA 10 mg/puff, cutaneous spray solution?
XILONIBSA 10 mg/puff, cutaneous spray solution requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in XILONIBSA 10 mg/puff, cutaneous spray solution?
The active ingredient in XILONIBSA 10 mg/puff, cutaneous spray solution is lidocaine. This information helps identify medicines with the same composition but different brand names.
Who manufactures XILONIBSA 10 mg/puff, cutaneous spray solution?
XILONIBSA 10 mg/puff, cutaneous spray solution is manufactured by Laboratorios Inibsa S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of XILONIBSA 10 mg/puff, cutaneous spray solution online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether XILONIBSA 10 mg/puff, cutaneous spray solution is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to XILONIBSA 10 mg/puff, cutaneous spray solution?
Other medicines with the same active substance (lidocaine) include ACTILOGIC 700 MG MEDICATED ADHESIVE DRESSING, DYNEXAN 20 mg/g BUCAL GEL, INSTILLIDO 20 mg/ml GEL. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media